rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Sitagliptin

Rediff.com  »  News  »   Sitagliptin

  News for Sitagliptin

  • Business

Sun Pharma, Merck to market diabetes drugs

Sun Pharmaceutical Industries Ltd and MSD in India said they have entered into a partnership to market diabetes drugs Sitagliptin and Sitaglipitin plus Metformin in the Indian market.Under the......

Merck & Co wins injunction against Indian firm over diabetes drugs

MSD, a unit of US drugmaker Merck & Co, said it has won an injunction against India's Aprica Pharmaceuticals and a source said this will stop Aprica launching generic versions of two diabetes drugs......

Drug patent row: HC to hear US co on Apr 12

Delhi High Court on Wednesday posted for April 12 an appeal filed by US pharmaceuticals major Merck Sharp and Dohme against the single judge bench order refusing to restrain Indian firm Glenmark......

MNCs' diabetes drug patents worry experts

Even as India is fast turning into the diabetes capital of the world, multinational drug companies are busy patenting new-generation diabetes medicines for exclusive marketing rights in the......
  Web results for Sitagliptin
Janssen's once-daily Invokamet XR receives US FDA approval to treat adults with type 2 diabetes

The US Food and Drug Administration (FDA) has approved Janssen Pharmaceuticals' Invokamet XR—a once-daily, fixed-dose combination therapy of... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=97632&sid=2
Merck, Pfizer announce phase 3 study of investigational oral SGLT2 inhibitor, ertugliflozin to treat patients with type 2 diabetes meets primary endpoint

Merck, known as MSD outside the United States and Canada, in partnership with Pfizer Inc. announced that a phase 3 study (VERTIS SITA2) of... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=97525&sid=2
First patient counselling centre in India at KEM Hospital benefits 3,500 patients

Jointly set up by KEM Hospital and Maharashtra State Pharmacy Council (MSPC), the first of its kind patient counselling centre (PCC) of India at... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=97410&sid=1
Janssen to Present Data from Nine Abstracts on INVOKANA® (canagliflozin) at 2016 European Association for the..

Janssen to Present Data from Nine Abstracts on INVOKANA® (canagliflozin) at 2016 European Association for the Study of Diabe... RARITAN, N.J.,... ...

http://in.advfn.com/news_Janssen-to-Present-Data-from-Nine-Abstracts-on-INV_72394646.html
GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors -..

Research and Markets has announced the addition of the "Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors,... ...

http://in.advfn.com/p.php?pid=nmona&article=72260819

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Related Pages


sitagliptin
Sitagliptin


0 Followers

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z